Sino Biopharmaceutical Limited
1177Biotechnology
HK$4.85−0.10%As of Oct 29vs prior close
- Market cap
- $11B
- P/E (TTM)
- 30.7×
- P/E (FY1)
- 15.7×
- From 52W high
- −32.57%
- EPS (TTM)
- –
- Revenue (LTM)
- CN¥33.7B
- Net margin
- 7.09%
- Dividend yield
- 2.47%
Nomior Score
47
Anchored CompounderBottom 43% of the scored universe
Growth46
Quality68
Value60
Momentum22
Resilience49
Growth
+6.95%revenue a year over 3 fiscal years
YE22 CN¥26BLTM CN¥33.7B
Connections
Revenue to profitYE25
7% of revenue became net profit, down 5 pts on a year.